Home › Nausea and Vomiting › NCT05520593
Preoperative Oral Hydration in the Ambulatory Arthroplasty Population
RecruitingHealthy volunteers welcome
Preoperative Oral Hydration in the Ambulatory Arthroplasty Population :A Single-Blinded Randomized Control Trial
Who can join
Ages 18 to 75 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Candidates for ambulatory total knee arthroplasty * Candidates for ambulatory total hip arthroplasty * Candidates for ambulatory revision knee arthroplasty (liner exchange only) * Candidates for ambulatory revision hip arthroplasty (liner exchange only) * Case scheduled before noon (12 pm) * Patient agrees to same-day discharge and has a responsible adult to spend the night on the day of discharge Exclusion Criteria: * BMI less than 18.5 or greater than 37.0 * Patients with diabetes, chronic kidney disease, clotting disorders, or neurological conditions preventing control of the affected limb. * Pregnant women * Patients scheduled as ambulatory due to insurance mandates * Patients with a history of active ischemia, significant valvular disease, significant arrhythmias, obstructive sleep apnea as per Hospital for Special Surgery guidelines, chronic opioid dependence (chronic daily opioid use for six or more months), and glomerular filtration rate \< 60ml/min.
About the study
The purpose of this study is to investigate if the consumption of a complex carbohydrate drink preoperatively, decreases the length of stay and causes for failure to launch in patients undergoing ambulatory total joint arthroplasty.
What is being tested
- Complex Carbohydrate Drink (dietary supplement)
Sponsor: Hospital for Special Surgery, New York · Participants: 312 · Started: Nov 7, 2022
Contact the study team
- Jose Rodriguez, MD · Phone: 212-552-5829
- Ricardo Torres-Ramirez, BS · Phone: 212-260-3763
Official record on ClinicalTrials.gov — NCT05520593
Locations in the U.S.
| New York | Hospital for Special Surgery, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.